F International Limited ("mF International" or the "Company"), today announced that it has received written notification (the "Notification Letter") from The Nasdaq Stock Market LLC ("Nasdaq") dated ...

SEIL Energy India Limited, one of the largest independent power producers (IPP) in India, here on Tuesday organized the Bhoomi Pooja for the Inclusive Sports Academy (ISA) at the Composite Regional ...

Young adults with early-onset colorectal cancer (EOCRC), particularly men and non-Hispanic Black and American Indian/Alaskan ...

The excitement of the University of Arizona commencement ceremony was muted at times by worries about the job market and ...

Cypherpunk Technologies Inc., (Nasdaq: CYPH) ("Cypherpunk"), today reported financial results for the first quarter ended March 31, 2026. "Since the start of 2026, Cypherpunk has advanced the mission ...

Announced encouraging preliminary safety and efficacy data across all three RAS-pathway inhibitor programsAnnounced publication in Cancer ...

Natera, Inc. ( NTRA) Q1 2026 Earnings Call May 7, 2026 4:30 PM EDT Ladies and gentlemen, welcome to Natera's First Quarter 2026 Financial Results Conference Call. As a reminder, this conference call ...

Good afternoon, and welcome to Verastem Oncology's First Quarter 2026 Earnings Conference Call. My name is Daniel, and I will be your call operator today. Please note, this event is being recorded.

Explore the 9 best supplement packaging design companies helping emerging wellness brands create standout, compliant, and ...

Announced encouraging preliminary safety and efficacy data across all three RAS-pathway inhibitor programsAnnounced publication in Cancer Discovery highlighting preclinical data demonstrating BBO-1181 ...

Five additional pivotal trials for pumitamig initiated during 2026 in collaboration with Bristol Myers SquibbOncology pipeline strength and combination strategy highlighted through multiple clinical ...

Q1 2026 Management view "This is a pivotal moment for our organization" following the RASolute 302 top-line readout, where "daraxonrasib monotherapy demonstrated an unprecedented improvement in ...